Filgotinib Maleate

N/A

Report date: 2026/05/02 20:00:18
NME

Base Information

Drug NameFilgotinib Maleate
Drug Alias NameFilgotinibum非戈替尼JyselecaG-146034-101GS-6034 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK1 inhibitors
TargetsTyrosine-protein kinase JAK1
Therapy Area/IndicationsAxial SpondyloarthritisImmunoglobulin G4-Related DiseaseLupus Erythematosus, Cutaneous +[17] 
Global Approved IndicationsArthritis, Rheumatoid
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2020/09/24
Country/TerritoryCzechiaBelgiumBulgaria +[50] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGalapagos Nv
China Registration ClassN/A

Develop Information

Active CompaniesGilead Sciences IncAlfasigma SpaGalapagos Nv +[5] 
Inactive CompaniesN/A
Active IndicationsAxial SpondyloarthritisImmunoglobulin G4-Related DiseaseLupus Nephritis +[11] 
Inactive IndicationsLupus Erythematosus, CutaneousRenal InsufficiencyGlomerulonephritis, Membranous +[6] 

Other Information

ATC CodeM01C
Related LinksWikipediaDrugBankKEGG